birb 796 has been researched along with bms 387032 in 5 studies
| Studies (birb 796) | Trials (birb 796) | Recent Studies (post-2010) (birb 796) | Studies (bms 387032) | Trials (bms 387032) | Recent Studies (post-2010) (bms 387032) |
|---|---|---|---|---|---|
| 137 | 5 | 80 | 76 | 3 | 56 |
| Protein | Taxonomy | birb 796 (IC50) | bms 387032 (IC50) |
|---|---|---|---|
| Cyclin-T1 | Homo sapiens (human) | 0.0103 | |
| G2/mitotic-specific cyclin-B2 | Homo sapiens (human) | 0.48 | |
| G1/S-specific cyclin-E2 | Homo sapiens (human) | 0.048 | |
| Vitamin K-dependent protein C | Homo sapiens (human) | 0.264 | |
| Cyclin-dependent kinase 1 | Homo sapiens (human) | 0.48 | |
| Cyclin-dependent kinase 4 | Homo sapiens (human) | 0.7538 | |
| G2/mitotic-specific cyclin-B1 | Homo sapiens (human) | 0.48 | |
| Cyclin-A2 | Homo sapiens (human) | 0.0427 | |
| G1/S-specific cyclin-D1 | Homo sapiens (human) | 0.925 | |
| G1/S-specific cyclin-E1 | Homo sapiens (human) | 0.046 | |
| Cyclin-dependent kinase 2 | Homo sapiens (human) | 0.0426 | |
| G1/S-specific cyclin-D2 | Homo sapiens (human) | 0.925 | |
| G1/S-specific cyclin-D3 | Homo sapiens (human) | 0.925 | |
| Cannabinoid receptor 2 | Mus musculus (house mouse) | 0.062 | |
| Cyclin-dependent kinase 7 | Homo sapiens (human) | 0.0772 | |
| Cyclin-dependent kinase 9 | Homo sapiens (human) | 0.1078 | |
| Cyclin-H | Homo sapiens (human) | 0.0823 | |
| CDK-activating kinase assembly factor MAT1 | Homo sapiens (human) | 0.1027 | |
| Cyclin-A1 | Homo sapiens (human) | 0.021 | |
| Cyclin-dependent-like kinase 5 | Homo sapiens (human) | 0.34 | |
| Cyclin-dependent kinase 5 activator 1 | Homo sapiens (human) | 0.34 | |
| G2/mitotic-specific cyclin-B3 | Homo sapiens (human) | 0.48 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atteridge, CE; Campbell, BT; Chan, KW; Ciceri, P; Davis, MI; Edeen, PT; Faraoni, R; Floyd, M; Gallant, P; Herrgard, S; Hunt, JP; Karaman, MW; Lockhart, DJ; Milanov, ZV; Morrison, MJ; Pallares, G; Patel, HK; Pritchard, S; Treiber, DK; Wodicka, LM; Zarrinkar, PP | 1 |
| Hajduk, PJ; Johnson, EF; Kifle, L; Merta, PJ; Metz, JT; Soni, NB | 1 |
| Russu, WA; Shallal, HM | 1 |
| Ciceri, P; Davis, MI; Herrgard, S; Hocker, M; Hunt, JP; Pallares, G; Treiber, DK; Wodicka, LM; Zarrinkar, PP | 1 |
| Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
5 other study(ies) available for birb 796 and bms 387032
| Article | Year |
|---|---|
A quantitative analysis of kinase inhibitor selectivity.
Topics: Binding Sites; Enzyme Activation; Humans; Phosphotransferases; Protein Binding; Protein Interaction Mapping; Protein Kinase Inhibitors; Proteome; Quantitative Structure-Activity Relationship | 2008 |
Navigating the kinome.
Topics: Drug Design; Pharmacogenetics; Protein Kinases; Proteome; Systems Biology | 2011 |
Discovery, synthesis, and investigation of the antitumor activity of novel piperazinylpyrimidine derivatives.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Molecular Structure; Piperazines; Protein Kinase Inhibitors; Protein Kinases; Pyrimidines; Stereoisomerism; Structure-Activity Relationship | 2011 |
Comprehensive analysis of kinase inhibitor selectivity.
Topics: Catalysis; Drug Design; Enzyme Stability; High-Throughput Screening Assays; Humans; Protein Binding; Protein Kinase Inhibitors; Protein Kinases; Proteomics; Signal Transduction; Substrate Specificity | 2011 |
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |